Evidence map›Paper›PMID 19393684›Full record

ReviewFrontiers in neuroendocrinology2009

Neuroprotective actions of androgens on motoneurons.

Keith N Fargo, Eileen M Foecking, Kathryn J Jones, Dale R Sengelaub

Abstract readReview
In one paragraph

Review in Frontiers in neuroendocrinology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 75 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Nuclear hormone receptors in demyelinating diseases.Journal of neuroendocrinology · 2022
    Review
  5. Sex and Gender Considerations in Episodic Migraine.Current pain and headache reports · 2022
    Review
  6. Article
  7. Steroid Sulfation in Neurodegenerative Diseases.Frontiers in molecular biosciences · 2022
    Review
  8. Review
  9. Article
  10. Androgen Therapy in Neurodegenerative Diseases.Journal of the Endocrine Society · 2020
    Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Keith N FargoResearch and Development Service, Edward Hines, Jr VA Hospital, Hines, IL, USA.
Eileen M Foecking
Kathryn J Jones
Dale R Sengelaub
Loyola University Chicago · USIndiana University Bloomington · US

Funding

TRAINING IN SPEECH, HEARING, AND SENSORY COMMUNICATIONST32DC000012 · NIDCD · TRUSTEES OF INDIANA UNIVERSITY · PI PISONI, DAVID B · 1988 to 2013
$7.7M
PREVENTION OF DENDRITIC ATROPHY AFTER MOTONEURON INJURYR01NS047264 · NINDS · TRUSTEES OF INDIANA UNIVERSITY · PI SENGELAUB, DALE R · 2005 to 2009
$979k
Androgens and molecular mediators of motoneuron repairF32NS052997 · NINDS · LOYOLA UNIVERSITY CHICAGO · PI FARGO, KEITH N · 2006 to 2008
$133k
NIDCD NIH HHS DC000012NIDCD NIH HHS T32 DC000012NINDS NIH HHS F32 NS052997NINDS NIH HHS NS047264NINDS NIH HHS NS052997NINDS NIH HHS R01 NS047264
6 · The paper itself

Abstract

Androgens have a variety of protective and therapeutic effects in both the central and peripheral nervous systems. Here we review these effects as they related specifically to spinal and cranial motoneurons. Early in development, androgens are critical for the formation of important neuromuscular sex differences, decreasing the magnitude of normally occurring cell death in select motoneuron populations. Throughout the lifespan, androgens also protect against motoneuron death caused by axonal injury. Surviving motoneurons also display regressive changes to their neurites as a result of both direct axonal injury and loss of neighboring motoneurons. Androgen treatment enhances the ability of motoneurons to recover from these regressive changes and regenerate both axons and dendrites, restoring normal neuromuscular function. Androgens exert these protective effects by acting through a variety of molecular pathways. Recent work has begun to examine how androgen treatment can interact with other treatment strategies in promoting recovery from motoneuron injury.

Indexed as

AndrogensAnimalsAxotomyCell DeathCell ShapeDendritesElectric StimulationMotor NeuronsNerve RegenerationNeuroprotective AgentsReceptors, AndrogenSex CharacteristicsAndrogensNeuroprotective AgentsReceptors, Androgen

Identifiers

PMID19393684
PMCPMC2726741
OpenAlexW2009206885

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.